Cargando…
WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells
Human cytochrome P450 1B1 (CYP1B1)-mediated biotransformation of endobiotics and xenobiotics plays an important role in the progression of human breast cancer. In this study, we investigated the effects of WY-14643, a peroxisome proliferator-activated receptor α (PPARα) agonist, on CYP1B1 expression...
Autores principales: | Hwang, Yong Pil, Won, Seong Su, Jin, Sun Woo, Lee, Gi Ho, Pham, Thi Hoa, Choi, Jae Ho, Kang, Keon Wook, Jeong, Hye Gwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928855/ https://www.ncbi.nlm.nih.gov/pubmed/31775380 http://dx.doi.org/10.3390/ijms20235928 |
Ejemplares similares
-
Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
por: Reddy, J. K., et al.
Publicado: (1978) -
Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
por: Lake, B G, et al.
Publicado: (1993) -
Characterization of WY 14,643 and its Complex with Aldose Reductase
por: Sawaya, Michael R., et al.
Publicado: (2016) -
Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes
por: Chen, Ke, et al.
Publicado: (2012) -
Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643
por: Wang, C, et al.
Publicado: (2004)